<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20260614069786N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-07-06</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>Does photobiomodulation with a 970-nm diode laser and neutral gel reduce pain during local anesthetic injection in maxillary anterior teeth?</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of the effect of 970-nm diode laser photobiomodulation combined with a neutral gel on pain perception during buccal infiltration anesthesia in maxillary anterior teeth</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-07-06</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>128</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>https://irct.ir/trial/90856</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Participants will be randomly allocated to one of the four study groups using variable block randomization with block sizes of 4 and 8. The random allocation sequence will be generated by an independent statistician. Allocation concealment will be ensured using sequentially numbered, opaque, sealed envelopes (SNOSE), Blinding description: Participants will be blinded to active versus sham laser allocation. Due to the nature of the intervention, operator blinding is not feasible.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Patients requiring buccal infiltration local anesthesia in the anterior maxillary region for dental procedures.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Participants will receive photobiomodulation using a 970-nm diode laser (Sirolaser Blue, Sirona Dental Systems GmbH, Germany) with a power output of 1.5 W in continuous-wave mode and an 800-µm fiber tip. Laser irradiation will be applied to the injection site for approximately 10–25 seconds. Standard buccal infiltration anesthesia will then be administered immediately. Intervention 2: Intervention group: A neutral gel without active ingredients will be applied to the injection site for one minute and subsequently removed. Sham laser application will then be performed using the same device appearance, sounds, aiming beam, duration, and positioning as active laser treatment, but without therapeutic energy emission. Standard buccal infiltration anesthesia will then be administered. Intervention 3: Intervention group: A neutral gel will be applied to the injection site for one minute. Active photobiomodulation with a 970-nm diode laser will then be delivered using the same parameters described for Group 1. The gel will subsequently be removed, and standard buccal infiltration anesthesia will be administered. Intervention 4: Control group: Participants will receive sham laser treatment without gel application, followed by standard buccal infiltration anesthesia.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is This study is still in the data collection phase and has not yet been completed. Therefore, the decision regarding the sharing of participants’ raw data will be made after the study is finished and data analysis is completed.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Nazanin Mohamadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Dentistry, Tehran University of Medical Sciences (TUMS) North Kargar Street (End), Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1439955991</zip>
        <telephone>+98 21 4279 4000</telephone>
        <email>nazaninmohammadi200@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Nazanin Mohamadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Dentistry, Tehran University of Medical Sciences (TUMS) North Kargar Street (End), Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1439955991</zip>
        <telephone>+98 21 4279 4000</telephone>
        <email>nazaninmohammadi200@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Adults aged 18 years and older.
Patients requiring buccal infiltration anesthesia in the maxillary anterior region for dental treatment.
American Society of Anesthesiologists (ASA) physical status I or II.
Ability to understand and complete the Visual Analog Scale (VAS) and Dental Anxiety Inventory (DAI).
Provision of written informed consent.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Lack of informed consent to participate in the study.
Known allergy to local anesthetic agents or contraindication to the use of epinephrine.
Uncontrolled systemic disease requiring specialized medical management.
Presence of inflammation, infection, abscess, wound, or any soft tissue lesion at the injection site.
Use of analgesics/NSAIDs, corticosteroids, sedatives, or anti-anxiety medications within 24 hours prior to the intervention.
Alcohol or stimulant substance use within the previous 24 hours.
Patients with acute dental pain, swelling, or requiring emergency dental treatment.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>R52</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Pain, unspecified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Participants will receive photobiomodulation using a 970-nm diode laser (Sirolaser Blue, Sirona Dental Systems GmbH, Germany) with a power output of 1.5 W in continuous-wave mode and an 800-µm fiber tip. Laser irradiation will be applied to the injection site for approximately 10–25 seconds. Standard buccal infiltration anesthesia will then be administered immediately.</i_keyword>
      <i_keyword>Intervention group: A neutral gel without active ingredients will be applied to the injection site for one minute and subsequently removed. Sham laser application will then be performed using the same device appearance, sounds, aiming beam, duration, and positioning as active laser treatment, but without therapeutic energy emission. Standard buccal infiltration anesthesia will then be administered.</i_keyword>
      <i_keyword>Intervention group: A neutral gel will be applied to the injection site for one minute. Active photobiomodulation with a 970-nm diode laser will then be delivered using the same parameters described for Group 1. The gel will subsequently be removed, and standard buccal infiltration anesthesia will be administered.</i_keyword>
      <i_keyword>Control group: Participants will receive sham laser treatment without gel application, followed by standard buccal infiltration anesthesia.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain induced by local anesthesia injection. Timepoint: Pain upon needle penetration (immediately after needle insertion into the mucosa and before anesthetic injection) and Pain during injection (immediately after completion of anesthetic solution injection). Method of measurement: Pain intensity will be measured using the Visual Analog Scale (VAS).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Dental anxiety level. Timepoint: before the intervention. Method of measurement: Dental Anxiety Inventory (DAI) questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-06-14</approval_date>
        <contact_name>Research Ethics Committees of School of Dentistry- Tehran university of Medical Science</contact_name>
        <contact_address>Faculty of Dentistry, Tehran University of Medical Sciences End of North Kargar Street, beside the Atomic Energy Organization of Iran, Before the East Hakim Expressway Exit, Tehran, Iran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
